Inoculations with AstraZeneca vaccine to continue, national committee says, addressing concerns

Inoculations with AstraZeneca’s Covid-19 vaccine should continue on schedule, the National Committee of Vaccinations said on Sunday, addressing concerns over side effects.

Responding to reports of “isolated thrombosis and embolism incidents” following inoculations with AstraZeneca’s vaccines, the committee cited the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee, which said there is no evidence that these episodes are causally linked with the vaccination.

The rate of such episodes, moreover, is not greater than the expected occurrence in the public in general, the national committee said, adding the same is true in the United Kingom after over 11 million vaccinations with AstraZeneca vaccines.

It further added that it is working with the Greek Pharmaceutical Organization to continuously monitor the safety of vaccines, following and reviewing any references to possible unwanted side-effects of Covid-19 vaccines.